<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02094482</url>
  </required_header>
  <id_info>
    <org_study_id>P08138.1</org_study_id>
    <nct_id>NCT02094482</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)</brief_title>
  <official_title>Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medartis AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medartis AG</source>
  <brief_summary>
    <textblock>
      Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive&#xD;
      Sleep Apnea (OSAS)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The new OSAS Implant is intended for use in the palate (hard and soft palate/ see picture&#xD;
      above) in order to stiffen and stabilize the soft palate, which may reduce the severity of&#xD;
      airway obstructions and of snoring in patients suffering from OSA (Obstructive Sleep Apnea).&#xD;
      Indications for use of the System include: symptomatic, habitual, social snoring due to&#xD;
      palatal flutter or upper airway obstruction primarily caused by the retropalatal obstruction.&#xD;
      The System is labeled for use by physicians only.&#xD;
&#xD;
      The primary endpoint is the Apnea-Hypopnea-Index (AHI) in the 90 days follow-up.&#xD;
&#xD;
      Study hypothesis: Reduction of initial AHI ≥20%&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">October 2020</completion_date>
  <primary_completion_date type="Actual">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of initial AHI by ≥20%</measure>
    <time_frame>90days</time_frame>
    <description>The primary endpoint is the Apnea-Hypopnea-Index (AHI) at the 90 days follow-up.&#xD;
Study hypothesis: Reduction of initial AHI ≥20%. AHI is measured using cardio-respiratory polygraphy. Two measurements are performed before treatment and at 90 days follow-up in order to reduce effects from night-to-night variability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of initial snoring index ≥30%</measure>
    <time_frame>90days</time_frame>
    <description>Endpoint snoring is measured on a continuous Visual Analog Scale (VAS) by the bed partner.&#xD;
Study hypothesis: Reduction of initial snoring index ≥30%</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Reduction of Initial AHI</condition>
  <condition>Reduction of Initial Snoaring Index</condition>
  <arm_group>
    <arm_group_label>OSAS Palatal Implant</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The IMD is a resilient palatal implant which is introduced through a stab incision into the palate. Two implants are placed underneath the rostral part of the palatal bone and continue into the upper part of the soft palate .</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The IMD is a resilient palatal implant which is introduced through a stab incision into the palate.</intervention_name>
    <description>The IMD is a resilient palatal implant which is introduced through a stab incision into the palate. Two implants are placed underneath the rostral part of the palatal bone and continue into the upper part of the soft palate</description>
    <arm_group_label>OSAS Palatal Implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Study patients must meet all of the following inclusion criteria:&#xD;
&#xD;
          -  Socially disturbing snoring with/without obstructive sleep apnea syndrome&#xD;
&#xD;
          -  Predominantly retropalatal obstructions established by ApneaGraph ≥60%, sleep&#xD;
             nasendoscopy or successful application of the Velumount palatal device&#xD;
&#xD;
          -  Findings for predominantly retropalatal obstructions in ENT-examination:&#xD;
&#xD;
          -  No tonsils or tonsils grade I - II&#xD;
&#xD;
          -  Normal finding of larynx and tongue base&#xD;
&#xD;
          -  No lingual tonsil hypertrophy&#xD;
&#xD;
          -  ASA (American Society of Anaesthesiology, 1963) criteria I or II&#xD;
&#xD;
          -  Body mass index (BMI) &lt; 33 kg/m2&#xD;
&#xD;
          -  Age &gt; 18 yrs&#xD;
&#xD;
          -  Fix bed partner&#xD;
&#xD;
          -  Ability to read and understand the patient's information&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous Pillar implants&#xD;
&#xD;
          -  Previous airway surgery other than nasal, adenoid, tonsil or UPPP&#xD;
&#xD;
          -  Presence of other sleep disorders&#xD;
&#xD;
          -  Psychiatric disorders&#xD;
&#xD;
          -  Neurological disorders (e.g. Cerebrovascular injury)&#xD;
&#xD;
          -  Dysmorphia of the cranial skeleton&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Known hypersensitivity to nitinol&#xD;
&#xD;
          -  Participation in another clinical study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kurt Tschopp, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Liestal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kantonsspital Liestal</name>
      <address>
        <city>Basel</city>
        <state>Baselland</state>
        <zip>4410</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 20, 2014</study_first_submitted>
  <study_first_submitted_qc>March 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2014</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Snoring</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

